Works by Neslusan, Cheryl

Results: 17

Fluoxetine and dothiepin therapy in primary care and health resource utilization: Evidence from the United Kingdom.

Published in:

International Journal of Psychiatry in Clinical Practice, 1999, v. 3, n. 1, p. 23, doi. 10.3109/13651509909024755

By:

Treglia, Michael;
Neslusan, Cheryl A.;
Dunn, Rodney L.

Publication type:

Article

Unmet need in major depressive disorder and acute suicidal ideation or behavior: findings from a longitudinal electronic health record data analysis.

Published in:

Journal of Medical Economics, 2023, v. 26, n. 1, p. 1, doi. 10.1080/13696998.2022.2133321

By:

Neslusan, Cheryl;
Chen, Yen-Wen;
Sharma, Mohit;
Voelker, Jennifer

Publication type:

Article

Estimating the moral-hazard effect of supplemental medical insurance in the demand for...

Published in:

American Economic Review, 1995, v. 85, n. 2, p. 122

By:

Coulson, N. Edward;
Terza, Joseph V.;
Neslusan, Cheryl A.;
Stuart, Bruce C.

Publication type:

Article

A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care.

Published in:

PharmacoEconomics, 2025, v. 43, n. 6, p. 601, doi. 10.1007/s40273-025-01478-z

By:

Willis, Michael S.;
Nilsson, Andreas;
Neslusan, Cheryl A.

Publication type:

Article

Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA.

Published in:

PharmacoEconomics, 2021, v. 39, n. 6, p. 707, doi. 10.1007/s40273-021-01042-5

By:

Zhdanava, Maryia;
Voelker, Jennifer;
Pilon, Dominic;
Cornwall, Tom;
Morrison, Laura;
Vermette-Laforme, Maude;
Lefebvre, Patrick;
Nash, Abigail I.;
Joshi, Kruti;
Neslusan, Cheryl

Publication type:

Article

Macrovascular Risk Equations Based on the CANVAS Program.

Published in:

2021

By:

Willis, Michael;
Asseburg, Christian;
Slee, April;
Nilsson, Andreas;
Neslusan, Cheryl

Publication type:

journal article

Characteristics of hospital encounters and associated economic burden of patients with major depressive disorder and acute suicidal ideation or behavior.

Published in:

Hospital Practice (2154-8331), 2021, v. 49, n. 3, p. 176, doi. 10.1080/21548331.2021.1886496

By:

Neslusan, Cheryl;
Voelker, Jennifer;
Lingohr-Smith, Melissa;
Lin, Jay

Publication type:

Article

Clinical and economic burden of major depressive disorder with acute suicidal ideation or behavior in a US Veterans Health Affairs database.

Published in:

Current Medical Research & Opinion, 2022, v. 38, n. 9, p. 1603, doi. 10.1080/03007995.2022.2081452

By:

Neslusan, Cheryl;
Chopra, Ishveen;
Joshi, Kruti;
Voelker, Jennifer

Publication type:

Article

Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data.

Published in:

Diabetes Therapy, 2020, v. 11, n. 11, p. 2657, doi. 10.1007/s13300-020-00923-w

By:

Willis, Michael;
Asseburg, Christian;
Slee, April;
Nilsson, Andreas;
Neslusan, Cheryl

Publication type:

Article

Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review.

Published in:

Diabetes Therapy, 2019, v. 10, n. 5, p. 1753, doi. 10.1007/s13300-019-00681-4

By:

Willis, Michael;
Asseburg, Christian;
Nilsson, Andreas;
Neslusan, Cheryl

Publication type:

Article

Cost-Effectiveness Analysis of Canagliflozin 300mg Versus Dapagliflozin 10mg Added to Metformin in Patients with Type 2 Diabetes in the United States.

Published in:

Diabetes Therapy, 2018, v. 9, n. 2, p. 565, doi. 10.1007/s13300-018-0371-y

By:

Neslusan, Cheryl;
Teschemaker, Anna;
Willis, Michael;
Johansen, Pierre;
Lien Vo

Publication type:

Article

Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK.

Published in:

Diabetes Therapy, 2017, v. 8, n. 5, p. 1175, doi. 10.1007/s13300-017-0312-1

By:

Evans, Marc;
Achha, Sayeed;
Neslusan, Cheryl

Publication type:

Article

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes.

Published in:

2003

By:

Cohen, Fredric J;
Neslusan, Cheryl A;
Conklin, Jonathan E;
Song, Xue

Publication type:

journal article

Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes.

Published in:

Diabetes Care, 2003, v. 26, n. 6, p. 1847, doi. 10.2337/diacare.26.6.1847

By:

Cohen, Fredric J.;
Neslusan, Cheryl A.;
Conklin, Jonathan E.;
Xue Song

Publication type:

Article

Lifetime benefits of early detection and treatment of diabetic kidney disease.

Published in:

PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217487

By:

Thornton Snider, Julia;
Sullivan, Jeffrey;
van Eijndhoven, Emma;
Hansen, Michael K.;
Bellosillo, Nobel;
Neslusan, Cheryl;
O’Brien, Ellen;
Riley, Ralph;
Seabury, Seth;
Kasiske, Bertram L.

Publication type:

Article

Cost-Effectiveness of Sulfonylureas versus Metformin as First-Line Therapy in Newly Diagnosed Type 2 Diabetes.

Published in:

Diabetes, 2007, v. 56, p. A318

By:

Willis, Michael;
Borg, Sixten;
Persson, Ulf;
Neslusan, Cheryl

Publication type:

Article

Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: a retrospective cohort study.

Published in:

BMC Endocrine Disorders, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12902-019-0417-9

By:

Wetmore, James B.;
Li, Suying;
Ton, Thanh G. N.;
Peng, Yi;
Hansen, Michael K.;
Neslusan, Cheryl;
Riley, Ralph;
Liu, Jiannong;
Gilbertson, David T.

Publication type:

Article